title: Dermatological complications of etanercept therapy for rheumatoid arthritis.
authors.forename: L
authors.initials: L
authors.lastname: Misery
authors.forename: J L
authors.initials: JL
authors.lastname: Perrot
authors.forename: A
authors.initials: A
authors.lastname: Gentil-Perret
authors.forename: B
authors.initials: B
authors.lastname: Pallot-Prades
authors.forename: F
authors.initials: F
authors.lastname: Cambazard
authors.forename: C
authors.initials: C
authors.lastname: Alexandre
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003449:Cryoglobulinemia / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008179:Lupus Erythematosus, Discoid / Q000139:chemically induced*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept